193 related articles for article (PubMed ID: 10945144)
1. [Metabolic difference between visceral fat and subcutaneous abdominal fat].
Björntorp P
Diabetes Metab; 2000 Jun; 26 Suppl 3():10-2. PubMed ID: 10945144
[TBL] [Abstract][Full Text] [Related]
2. The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes.
Bonen A; Tandon NN; Glatz JF; Luiken JJ; Heigenhauser GJ
Int J Obes (Lond); 2006 Jun; 30(6):877-83. PubMed ID: 16418758
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of leptin levels in plasma and their reliance on other hormonal factors affecting tissue fat levels in people with various levels of endogenous cotisol].
Robaczyk MG
Ann Acad Med Stetin; 2002; 48():283-300. PubMed ID: 14601484
[TBL] [Abstract][Full Text] [Related]
4. Contributions of total body fat, abdominal subcutaneous adipose tissue compartments, and visceral adipose tissue to the metabolic complications of obesity.
Smith SR; Lovejoy JC; Greenway F; Ryan D; deJonge L; de la Bretonne J; Volafova J; Bray GA
Metabolism; 2001 Apr; 50(4):425-35. PubMed ID: 11288037
[TBL] [Abstract][Full Text] [Related]
5. Depot-specific hormonal characteristics of subcutaneous and visceral adipose tissue and their relation to the metabolic syndrome.
Wajchenberg BL; Giannella-Neto D; da Silva ME; Santos RF
Horm Metab Res; 2002; 34(11-12):616-21. PubMed ID: 12660870
[TBL] [Abstract][Full Text] [Related]
6. Growth hormone and the metabolic syndrome.
Johannsson G; Bengtsson BA
J Endocrinol Invest; 1999; 22(5 Suppl):41-6. PubMed ID: 10442570
[TBL] [Abstract][Full Text] [Related]
7. Obesity and metabolic complications: contribution of dehydroepiandrosterone and other steroid hormones.
Tchernof A; Labrie F; Bélanger A; Després JP
J Endocrinol; 1996 Sep; 150 Suppl():S155-64. PubMed ID: 8943799
[TBL] [Abstract][Full Text] [Related]
8. High visceral and low abdominal subcutaneous fat stores in the obese adolescent: a determinant of an adverse metabolic phenotype.
Taksali SE; Caprio S; Dziura J; Dufour S; Calí AM; Goodman TR; Papademetris X; Burgert TS; Pierpont BM; Savoye M; Shaw M; Seyal AA; Weiss R
Diabetes; 2008 Feb; 57(2):367-71. PubMed ID: 17977954
[TBL] [Abstract][Full Text] [Related]
9. Molecular evidence supporting the portal theory: a causative link between visceral adiposity and hepatic insulin resistance.
Kabir M; Catalano KJ; Ananthnarayan S; Kim SP; Van Citters GW; Dea MK; Bergman RN
Am J Physiol Endocrinol Metab; 2005 Feb; 288(2):E454-61. PubMed ID: 15522994
[TBL] [Abstract][Full Text] [Related]
10. Relationship between fat cell size and number and fatty acid composition in adipose tissue from different fat depots in overweight/obese humans.
Garaulet M; Hernandez-Morante JJ; Lujan J; Tebar FJ; Zamora S
Int J Obes (Lond); 2006 Jun; 30(6):899-905. PubMed ID: 16446749
[TBL] [Abstract][Full Text] [Related]
11. [Android-type obesity and gynecoid-type obesity].
Janjic D
Praxis (Bern 1994); 1996 Dec; 85(49):1578-83. PubMed ID: 8992575
[TBL] [Abstract][Full Text] [Related]
12. Comparison of body fat composition and serum adiponectin levels in diabetic obesity and non-diabetic obesity.
Kim C; Park J; Park J; Kang E; Ahn C; Cha B; Lim S; Kim K; Lee H
Obesity (Silver Spring); 2006 Jul; 14(7):1164-71. PubMed ID: 16899797
[TBL] [Abstract][Full Text] [Related]
13. [Body fat distribution: its characteristics and relationship to cardiovascular risk factors in obese Chinese].
Ran XW; Li XS; Tong NW; Li QF; Tang BD; Li XJ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Sep; 35(5):699-703. PubMed ID: 15460424
[TBL] [Abstract][Full Text] [Related]
14. Modulation of adipocyte lipoprotein lipase expression as a strategy for preventing or treating visceral obesity.
McCarty MF
Med Hypotheses; 2001 Aug; 57(2):192-200. PubMed ID: 11461172
[TBL] [Abstract][Full Text] [Related]
15. Lipid metabolism in women.
Williams CM
Proc Nutr Soc; 2004 Feb; 63(1):153-60. PubMed ID: 15070445
[TBL] [Abstract][Full Text] [Related]
16. Is visceral obesity the cause of the metabolic syndrome?
Després JP
Ann Med; 2006; 38(1):52-63. PubMed ID: 16448989
[TBL] [Abstract][Full Text] [Related]
17. Resistin and adiponectin expression in visceral fat of obese rats: effect of weight loss.
Milan G; Granzotto M; Scarda A; Calcagno A; Pagano C; Federspil G; Vettor R
Obes Res; 2002 Nov; 10(11):1095-103. PubMed ID: 12429872
[TBL] [Abstract][Full Text] [Related]
18. Effect of fat distribution on the pharmacokinetics of cortisol in obesity.
Lottenberg SA; Giannella-Neto D; Derendorf H; Rocha M; Bosco A; Carvalho SV; Moretti AE; Lerário AC; Wajchenberg BL
Int J Clin Pharmacol Ther; 1998 Sep; 36(9):501-5. PubMed ID: 9760012
[TBL] [Abstract][Full Text] [Related]
19. Dysregulation of the autonomic nervous system can be a link between visceral adiposity and insulin resistance.
Lindmark S; Lönn L; Wiklund U; Tufvesson M; Olsson T; Eriksson JW
Obes Res; 2005 Apr; 13(4):717-28. PubMed ID: 15897481
[TBL] [Abstract][Full Text] [Related]
20. Is visceral fat involved in the pathogenesis of the metabolic syndrome? Human model.
Jensen MD
Obesity (Silver Spring); 2006 Feb; 14 Suppl 1():20S-24S. PubMed ID: 16642959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
